Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Oct 29, 2026
- Incorporated
- Delaware
- Filings on record
- 652 filings
- On EDGAR
- CIK 1607678
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 47
News 8 of 110
Prospectuses and Registrations 8 of 74
- 424B5 Prospectus supplement for an offering Sep 25, 2026
- 424B5 Prospectus supplement for an offering Sep 25, 2026
- FWP Free writing prospectus Sep 24, 2026
- 424B5 Prospectus supplement for an offering Sep 23, 2026
- 424B5 Prospectus supplement for an offering Sep 23, 2026
- S-3ASR Automatic shelf registration Jul 30, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
Proxies 8 of 26
- DEFA14A Extra proxy material Apr 1, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEFR14A Apr 23, 2025
- DEFA14A Extra proxy material Apr 8, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2025
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
Ownership 8 of 326
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 4 Insider reported a trade Aug 7, 2026
- 3 Insider reported their initial holding Aug 7, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 29, 2026
Other 8 of 69
- 305B2 Sep 24, 2026
- ARS Annual report sent to shareholders Apr 1, 2026
- UPLOAD Comment letter from SEC staff Apr 21, 2025
- CORRESP Reply to SEC staff Apr 8, 2025
- ARS Annual report sent to shareholders Apr 8, 2025
- UPLOAD Comment letter from SEC staff Mar 31, 2025
- ARS Annual report sent to shareholders Apr 5, 2024
- ARS Annual report sent to shareholders May 1, 2023
Everything here comes from Viking Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.